Europe Secondary Hyperoxaluria Drug Market Analysis, Demand & Growth Forecast

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF EUROPE SECONDARY HYPEROXALURIA DRUG MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET END USER COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PIPELINE ANALYSIS

5 REGULATORY SCENARIO OF EUROPE SECONDARY HYPEROXALURIA DRUG MARKET

5.1 REGULATORY FRAMEWORK FOR PROBIOTICS

5.2 REGULATORY FRAMEWORK FOR EUROPE

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 TARGETED TREATMENT FOR SECONDARY HYPEROXALURIA IS IN HIGH DEMAND

6.1.2 R&D INVESTMENT IN COMPANIES FOCUSING ON DRUG DEVELOPEMENT

6.1.3 LOW DIETARY AWARENESS IN UPPER SOCIO-ECONOMIC SOCIETY

6.1.4 INCREASED NUMBER OF CASES FOR SECONDARY HYPEROXALURIA

6.1.5 LOSS OF OXALOBACTER FORMIGENES

6.2 RESTRAINTS

6.2.1 LIMITED OPERATING REVENUE

6.2.2 HIGH COST OF TREATING SECONDARY HYPEROXALURIA

6.2.3 LIMITED SECONDARY THERAPEUTICS OPTION FOR TREATMENT

6.3 OPPORTUNITIES

6.3.1 DIFFICULTY IN MAINTAINING LOW OXALATE DIET

6.3.2 INCREASING NUMBER OF BARIATRIC SURGERY

6.3.3 REGULATORY SUPPORT FOR APPROVAL

6.3.4 RISING DISPOSABLE INCOME

6.4 CHALLENGES

6.4.1 DELAY IN DIAGNOSIS OF DISEASE LEADING TO NEED FOR RENAL REPLACEMENT

6.4.2 INCREASE FITNESS AWARENESS AMONG PEOPLE

6.4.3 INCREASE FLUID INTAKE AS A PREVENTIVE MEASURES

7 COVID-19 IMPACT ON EUROPE SECONDARY HYPEROXALURIA DRUG MARKET

7.1 OVERVIEW

7.2 PRICE IMPACT

7.3 IMPACT ON DEMAND

7.4 IMPACT ON SUPPLY CHAIN

7.5 STRATEGIC DECISIONS FOR MANUFACTURERS

7.6 CONCLUSION

8 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE

8.1 OVERVIEW

8.2 SUPPLEMENTS

8.2.1 OXALATE BINDING AGENTS

8.2.1.1 CALCIUM SUPPLEMENTS

8.2.1.2 MAGNESIUM SUPPLEMENTS

8.2.1.3 OTHERS

8.2.2 CITRATE SUPPLEMENTS

8.2.3 PYRIDOXINE SUPPLEMENTS

8.2.4 PROBIOTICS

8.3 THIAZIDE DIURETICS

8.4 RELOXALIASE

9 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET, BY DRUG TYPE

9.1 OVERVIEW

9.2 OVER THE COUNTER

9.3 PRESCRIPTION

10 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET, BY POPULATION TYPE

10.1 OVERVIEW

10.2 ADULTS

10.3 CHILDREN

11 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET, BY END USER

11.1 OVERVIEW

11.2 HOME HEALTHCARE

11.3 HOSPITALS

11.4 SPECIALTY CLINICS

11.5 OTHERS

12 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET, BY DISTRIBUTION CHANNEL

12.1 OVERVIEW

12.2 RETAIL PHARMACIES

12.3 HOSPITAL PHARMACIES

12.4 ONLINE PHARMACIES

12.5 OTHERS

13 EUROPE SECONDARY HYPEROXLURIA DRUG MARKET, BY GEOGRAPHY

13.1 EUROPE

13.1.1 GERMANY

13.1.2 FRANCE

13.1.3 U.K.

13.1.4 ITALY

13.1.5 SPAIN

13.1.6 RUSSIA

13.1.7 POLAND

13.1.8 TURKEY

13.1.9 SWITZERLAND

13.1.10 NETHERLANDS

13.1.11 BELGIUM

13.1.12 HUNGARY

13.1.13 AUSTRIA

13.1.14 NORWAY

13.1.15 IRELAND

13.1.16 LITHUANIA

13.1.17 REST OF EUROPE

14 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: EUROPE

15 COMPANY PROFILE

15.1 NESTLE

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 COMPANY SHARE ANALYSIS

15.1.4 PRODUCT PORTFOLIO

15.1.5 RECENT DEVELOPMENTS

15.2 GLAXOSMITHKLINE PLC

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYSIS

15.2.3 COMPANY SHARE ANALYSIS

15.2.4 PRODUCT PORTFOLIO

15.2.5 RECENT DEVELOPMENT

15.3 BAYER AG

15.3.1 COMPANY SNAPSHOT

15.3.2 REVENUE ANALYSIS

15.3.3 COMPANY SHARE ANALYSIS

15.3.4 PRODUCT PORTFOLIO

15.3.5 RECENT DEVELOPMENTS

15.4 NOW FOODS

15.4.1 COMPANY SNAPSHOT

15.4.2 COMPANY SHARE ANALYSIS

15.4.3 PRODUCT PORTFOLIO

15.4.4 RECENT DEVELOPMENTS

15.5 SOLGAR INC.

15.5.1 COMPANY SNAPSHOT

15.5.2 COMPANY SHARE ANALYSIS

15.5.3 PRODUCT PORTFOLIO

15.5.4 RECENT DEVELOPMENT

15.6 PHARMAVITE

15.6.1 COMPANY SNAPSHOT

15.6.2 PRODUCT PORTFOLIO

15.6.3 RECENT DEVELOPMENTS

15.7 INFINITUS (CHINA)

15.7.1 COMPANY SNAPSHOT

15.7.2 PRODUCT PORTFOLIO

15.7.3 RECENT DEVELOPMENTS

15.8 MISSION PHARMACAL COMPANY

15.8.1 COMPANY SNAPSHOT

15.8.2 PRODUCT PORTFOLIO

15.8.3 .RECENT DEVELOPMENT

15.9 OYSTER SHELL

15.9.1 COMPANY SNAPSHOT

15.9.2 PRODUCT PORTFOLIO

15.9.3 RECENT DEVELOPMENT

15.1 ALLENA PHARMACEUTICALS, INC.

15.10.1 COMPANY SNAPSHOT

15.10.2 PRODUCT PORTFOLIO

15.10.3 RECENT DEVELOPMENTS

15.11 AMWAY CORP.

15.11.1 COMPANY SNAPSHOT

15.11.2 PRODUCT PORTFOLIO

15.11.3 RECENT DEVELOPMENTS

15.12 CELEBRATE VITAMINS

15.12.1 COMPANY SNAPSHOT

15.12.2 PRODUCT PORTFOLIO

15.12.3 RECENT DEVELOPMENTS

15.13 ENTRING, LLC

15.13.1 COMPANY SNAPSHOT

15.13.2 PRODUCT PORTFOLIO

15.13.3 RECENT DEVELOPMENTS

15.14 NATURE’S BOUNTY

15.14.1 COMPANY SNAPSHOT

15.14.2 PRODUCT PORTFOLIO

15.14.3 RECENT DEVELOPMENT

15.15 OXTHERA

15.15.1 COMPANY SNAPSHOT

15.15.2 PRODUCT PORTFOLIO

15.15.3 RECENT DEVELOPMENT

15.16 RENEW LIFE FORMULAS, INC.

15.16.1 COMPANY SNAPSHOT

15.16.2 PRODUCT PORTFOLIO

15.16.3 RECENT DEVELOPMENTS

15.17 SYNLOGIC

15.17.1 COMPANY SNAPSHOT

15.17.2 REVENUE ANALYSIS

15.17.3 PRODUCT PORTFOLIO

15.17.4 RECENT DEVELOPMENTS

15.18 TIENS

15.18.1 COMPANY SNAPSHOT

15.18.2 PRODUCT PORTFOLIO

15.18.3 RECENT DEVELOPMENTS

16 QUESTIONNAIRE

17 RELATED REPORTS

List of Table

LIST OF TABLES

TABLE 1 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET, PIPELINE ANALYSIS

TABLE 2 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: BY TYPE, 2019-2028 (USD MILLION)

TABLE 3 EUROPE SUPPLEMENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 4 EUROPE SUPPLEMENTS IN SECONDARY HYPEROXALURIA DRUG MARKET: BY TYPE, 2019-2028 (USD MILLION)

TABLE 5 EUROPE OXALATE BINDING AGENTS IN SECONDARY HYPEROXALURIA DRUG MARKET: BY TYPE, 2019-2028 (USD MILLION)

TABLE 6 EUROPE THIAZIDE DIURETICS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 7 EUROPE RELOXALIASE IN SECONDARY HYPEROXALURIA DRUG MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 8 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 9 EUROPE OVER THE COUNTER IN SECONDARY HYPEROXALURIA DRUG MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 EUROPE PRESCRIPTION IN SECONDARY HYPEROXALURIA DRUG MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 12 EUROPE ADULTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 EUROPE CHILDREN IN SECONDARY HYPEROXALURIA DRUG MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 15 EUROPE HOME HEALTHCARE IN SECONDARY HYPEROXALURIA DRUG MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 EUROPE HOSPITALS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 EUROPE SPECIALTY CLINICS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 EUROPE OTHERS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 19 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 20 EUROPE RETAIL PHARMACIES IN SECONDARY HYPEROXALURIA DRUG MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 EUROPE HOSPITAL PHARMACIES IN SECONDARY HYPEROXALURIA DRUG MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 EUROPE ONLINE PHARMACIES IN SECONDARY HYPEROXALURIA DRUG MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 EUROPE OTHERS PHARMACIES IN SECONDARY HYPEROXALURIA DRUG MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 25 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 26 EUROPE SUPPLEMENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 27 EUROPE OXALATE-BINDING AGENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 28 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 29 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 30 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 31 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 32 GERMANY SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 33 GERMANY SUPPLEMENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 34 GERMANY OXALATE-BINDING AGENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 35 GERMANY SECONDARY HYPEROXALURIA DRUG MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 36 GERMANY SECONDARY HYPEROXALURIA DRUG MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 37 GERMANY SECONDARY HYPEROXALURIA DRUG MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 38 GERMANY SECONDARY HYPEROXALURIA DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 39 FRANCE SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 40 FRANCE SUPPLEMENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 41 FRANCE OXALATE-BINDING AGENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 42 FRANCE SECONDARY HYPEROXALURIA DRUG MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 43 FRANCE SECONDARY HYPEROXALURIA DRUG MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 44 FRANCE SECONDARY HYPEROXALURIA DRUG MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 45 FRANCE SECONDARY HYPEROXALURIA DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 46 U.K. SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 47 U.K. SUPPLEMENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 48 U.K. OXALATE-BINDING AGENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 49 U.K. SECONDARY HYPEROXALURIA DRUG MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 50 U.K. SECONDARY HYPEROXALURIA DRUG MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 51 U.K. SECONDARY HYPEROXALURIA DRUG MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 52 U.K. SECONDARY HYPEROXALURIA DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 53 ITALY SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 54 ITALY SUPPLEMENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 55 ITALY OXALATE-BINDING AGENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 56 ITALY SECONDARY HYPEROXALURIA DRUG MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 57 ITALY SECONDARY HYPEROXALURIA DRUG MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 58 ITALY SECONDARY HYPEROXALURIA DRUG MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 59 ITALY SECONDARY HYPEROXALURIA DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 60 SPAIN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 61 SPAIN SUPPLEMENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 62 SPAIN OXALATE-BINDING AGENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 63 SPAIN SECONDARY HYPEROXALURIA DRUG MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 64 SPAIN SECONDARY HYPEROXALURIA DRUG MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 65 SPAIN SECONDARY HYPEROXALURIA DRUG MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 66 SPAIN SECONDARY HYPEROXALURIA DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 67 RUSSIA SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 68 RUSSIA SUPPLEMENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 69 RUSSIA OXALATE-BINDING AGENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 70 RUSSIA SECONDARY HYPEROXALURIA DRUG MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 71 RUSSIA SECONDARY HYPEROXALURIA DRUG MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 72 RUSSIA SECONDARY HYPEROXALURIA DRUG MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 73 RUSSIA SECONDARY HYPEROXALURIA DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 74 POLAND SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 75 POLAND SUPPLEMENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 76 POLAND OXALATE-BINDING AGENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 77 POLAND SECONDARY HYPEROXALURIA DRUG MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 78 POLAND SECONDARY HYPEROXALURIA DRUG MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 79 POLAND SECONDARY HYPEROXALURIA DRUG MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 80 POLAND SECONDARY HYPEROXALURIA DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 81 TURKEY SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 82 TURKEY SUPPLEMENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 83 TURKEY OXALATE-BINDING AGENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 84 TURKEY SECONDARY HYPEROXALURIA DRUG MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 85 TURKEY SECONDARY HYPEROXALURIA DRUG MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 86 TURKEY SECONDARY HYPEROXALURIA DRUG MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 87 TURKEY SECONDARY HYPEROXALURIA DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 88 SWITZERLAND SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 89 SWITZERLAND SUPPLEMENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 90 SWITZRLAND OXALATE-BINDING AGENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 91 SWITZERLAND SECONDARY HYPEROXALURIA DRUG MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 92 SWITZERLAND SECONDARY HYPEROXALURIA DRUG MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 93 SWITZERLAND SECONDARY HYPEROXALURIA DRUG MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 94 SWITZERLAND SECONDARY HYPEROXALURIA DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 95 NETHERLANDS SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 96 NETHERLANDS SUPPLEMENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 97 NETHERLANDS OXALATE-BINDING AGENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 98 NETHERLANDS SECONDARY HYPEROXALURIA DRUG MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 99 NETHERLANDS SECONDARY HYPEROXALURIA DRUG MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 100 NETHERLANDS SECONDARY HYPEROXALURIA DRUG MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 101 NETHERLANDS SECONDARY HYPEROXALURIA DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 102 BELGIUM SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 103 BELGIUM SUPPLEMENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 104 BELGIUM OXALATE-BINDING AGENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 105 BELGIUM SECONDARY HYPEROXALURIA DRUG MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 106 BELGIUM SECONDARY HYPEROXALURIA DRUG MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 107 BELGIUM SECONDARY HYPEROXALURIA DRUG MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 108 BELGIUM SECONDARY HYPEROXALURIA DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 109 HUNGARY SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 110 HUNGARY SUPPLEMENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 111 HUNGARY OXALATE-BINDING AGENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 112 HUNGARY SECONDARY HYPEROXALURIA DRUG MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 113 HUNGARY SECONDARY HYPEROXALURIA DRUG MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 114 HUNGARY SECONDARY HYPEROXALURIA DRUG MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 115 HUNGARY SECONDARY HYPEROXALURIA DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 116 AUSTRIA SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 117 AUSTRIA SUPPLEMENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 118 AUSTRIA OXALATE-BINDING AGENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 119 AUSTRIA SECONDARY HYPEROXALURIA DRUG MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 120 AUSTRIA SECONDARY HYPEROXALURIA DRUG MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 121 AUSTRIA SECONDARY HYPEROXALURIA DRUG MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 122 AUSTRIA SECONDARY HYPEROXALURIA DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 123 NORWAY SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 124 NORWAY SUPPLEMENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 125 NORWAY OXALATE-BINDING AGENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 126 NORWAY SECONDARY HYPEROXALURIA DRUG MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 127 NORWAY SECONDARY HYPEROXALURIA DRUG MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 128 NORWAY SECONDARY HYPEROXALURIA DRUG MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 129 NORWAY SECONDARY HYPEROXALURIA DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 130 IRELAND SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 131 IRELAND SUPPLEMENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 132 IRELAND OXALATE-BINDING AGENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 133 IRELAND SECONDARY HYPEROXALURIA DRUG MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 134 IRELAND SECONDARY HYPEROXALURIA DRUG MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 135 IRELAND SECONDARY HYPEROXALURIA DRUG MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 136 IRELAND SECONDARY HYPEROXALURIA DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 137 LITHUANIA SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 138 LITHUANIA SUPPLEMENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 139 LITHUANIA OXALATE-BINDING AGENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 140 LITHUANIA SECONDARY HYPEROXALURIA DRUG MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 141 LITHUANIA SECONDARY HYPEROXALURIA DRUG MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 142 LITHUANIA SECONDARY HYPEROXALURIA DRUG MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 143 LITHUANIA SECONDARY HYPEROXALURIA DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 144 REST OF EUROPE SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

List of Figure

LIST OF FIGURES

FIGURE 1 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: SEGMENTATION

FIGURE 2 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: DROC ANALYSIS

FIGURE 4 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: EUROPE VS REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: MULTIVARIATE MODELLING

FIGURE 7 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: MARKET END USER COVERAGE GRID

FIGURE 10 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: SEGMENTATION

FIGURE 12 LOW DIETARY AWARENESS IN UPPER SOCIO-ECONOMIC SOCIETY IS EXPECTED TO DRIVE THE EUROPE SECONDARY HYPEROXALURIA DRUG MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 SUPPLEMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE SECONDARY HYPEROXALURIA DRUG MARKET IN 2021 & 2028

FIGURE 14 EUROPE IS THE FASTEST GROWING REGION FOR SECONDARY HYPEROXALURIA DRUG MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 15 REGULATORY FRAMEWORK FOR PROBIOTICS

FIGURE 16 DRIVERS, RESTRAINT, OPPORTUNITIES AND CHALLENGE OF EUROPE SECONDARY HYPEROXALURIA DRUG MARKET

FIGURE 17 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: BY TYPE, 2020

FIGURE 18 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: BY TYPE, 2020-2028 (USD MILLION)

FIGURE 19 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: BY TYPE, CAGR (2021-2028)

FIGURE 20 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: BY TYPE, LIFELINE CURVE

FIGURE 21 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: BY DRUG TYPE, 2020

FIGURE 22 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: BY DRUGS CLASS, 2020-2028 (USD MILLION)

FIGURE 23 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: BY DRUG TYPE, CAGR (2021-2028)

FIGURE 24 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: BY DRUG TYPE, LIFELINE CURVE

FIGURE 25 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: BY POPULATION TYPE, 2020

FIGURE 26 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: BY POPULATION TYPE, 2020-2028 (USD MILLION)

FIGURE 27 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: BY POPULATION TYPE, CAGR (2021-2028)

FIGURE 28 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: BY POPULATION TYPE, LIFELINE CURVE

FIGURE 29 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: BY END USER, 2020

FIGURE 30 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: BY END USER, 2020-2028 (USD MILLION)

FIGURE 31 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: BY END USER, CAGR (2021-2028)

FIGURE 32 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: BY END USER, LIFELINE CURVE

FIGURE 33 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 34 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: BY DISTRIBUTION CHANNEL, 2020-2028 (USD MILLION)

FIGURE 35 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)

FIGURE 36 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 37 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: SNAPSHOT (2020)

FIGURE 38 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: BY COUNTRY (2020)

FIGURE 39 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: BY COUNTRY (2021 & 2028)

FIGURE 40 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: BY COUNTRY (2021 & 2028)

FIGURE 41 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: BY TYPE (2021-2028)

FIGURE 42 EUROPE SECONDARY HYPEROXALURIA DRUG MARKET: COMPANY SHARE 2020 (%)